Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 42Leukemia 35Lymphoma 19Myelodysplastic Syndromes 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Non-Hodgkin 13Hodgkin Disease 13Leukemia, Myeloid, Acute 12Multiple Myeloma 11Myeloproliferative Disorders 9Recurrence 8Lymphoma, T-Cell, Peripheral 8Lymphoma, Mantle-Cell 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, B-Cell, Marginal Zone 7Burkitt Lymphoma 7Lymphoma, T-Cell, Cutaneous 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 6Hematologic Neoplasms 6Congenital Abnormalities 6Waldenstrom Macroglobulinemia 5Sezary Syndrome 5Primary Myelofibrosis 5Neoplasms, Plasma Cell 5Mycosis Fungoides 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Anemia, Aplastic 5Myelodysplastic-Myeloproliferative Diseases 4

Interventions

spartalizumab 1sabatolimab 1ruxolitinib 1lintuzumab 1filanesib 1Stem Cell Transplantation 1Sampling Studies 1Melphalan 1Lenalidomide 1Decitabine 1Clofarabine 1CPI-0610 1Azacitidine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Preleukemia × Alemtuzumab × Clear all
NCT00943592 2014-02-27

Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies

University of Chicago

Phase 1/2 Completed
82 enrolled 12 charts
Other hematologic neoplasm

Leukemia, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡